Vum01 0006 01
Vumerity Capsule
Product Images NDC 64406-020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Vumerity (NDC 64406-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vum01 0006 02
Vum01 0006 03
VUMERITY is a prescription medication in capsule form that contains 31mg of diroximel fumarate. It is used as a treatment for specific medical conditions. The recommended dosage is available in the prescription information. The medication should be stored at a temperature of 2°C to 25°C. For more information and support, visit the VUMERITY website or call 1-800-456-2255. This information is only available in English.*
Vum01 0006 04
NDC 64406-020-01 is a medication called VUMERITY, which comes in delayed-release capsules containing 231 mg of diroximel fumarate. The recommended dosage can be found in the prescribing information, and the capsules should be swallowed whole. The medication should be stored at room temperature, between 20°C to 25°C, with limited excursions to 15°C to 30°C. Information and support can be obtained from VUMERITY.com, and the medication is manufactured by Biogen Inc. in Massachusetts, USA. The lot number and expiration date are also provided.*
Vum01 0006 05
VUMERITY (diroximel fumarate) delayed-release capsules are a medication for maintenance doses. Each capsule contains 31mg of the compound. It is suggested to swallow the capsule whole. Recommended dosage instructions can be found in the prescription information. VUMERITY is produced by Biogens and can be contacted through +800-456.255 or www.vumerity.com.*
Vum01 0006 06
This is a drug product labeled VUMERITY, with the National Drug Code (NDC) 64406-020-03. The recommended dosage should be consulted on the prescribing information. The drug contains 231 mg of diroximel fumarate and is available as a delayed-release capsule meant to be swallowed whole. The medicine must be stored at a temperature between 20°C to 25°C with excursions permitted to 15°C to 30°C. Informational and support services can be obtained by calling at 1-600-456-2255. The product is manufactured for Biogen Inc. located in Cambridge, Massachusetts, and has been produced in the United Kingdom. Lastly, the specific lot number for the capsules and its expiration date is provided; however, the details have been omitted from the text.*
Vum01 0006 07
Vum01 0006 08
VUMERITY is a prescription medication. It contains 231 mg of diroximel fumarate and comes in delayed-release capsules. The recommended dosage is indicated in the prescribing information. The medicine should be stored at 20°C to 25°C (68°F to 77°F) and excursions permitted to15°C to 30°C (59°F to 86°F). For more information and support, contact 1-800-456-2255 or visit VUMERITY.com. The medicine is manufactured by Biogen|nc, Cambridge, MA 02142, and is a product of the United Kingdom. LOT XXX-XXXXX, EXP YYYY-MM, and the NDC number are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
